Asymmetric Total Synthesis and Identification of Tetrahydroprotoberberine Derivatives As New Antipsychotic Agents Possessing a Dopamine D1, D2 and Serotonin 5-HT1A Multi-Action Profile

Haifeng Sun,Liyuan Zhu,Huicui Yang,Wangke Qian,Lin Guo,Shengbin Zhou,Bo Gao,Zeng Li,Yu Zhou,Hualiang Jiang,Kaixian Chen,Xuechu Zhen,Hong Liu
DOI: https://doi.org/10.1016/j.bmc.2012.12.016
IF: 3.461
2013-01-01
Bioorganic & Medicinal Chemistry
Abstract:An effective and rapid method for the microwave-assisted preparation of the key intermediate for the total synthesis of tetrahydroprotoberberines (THPBs) including l-stepholidine (l-SPD) was developed. Thirty-one THPB derivatives with diverse substituents on A and D ring were synthesized, and their binding affinity to dopamine D(1), D(2) and serotonin 5-HT(1A) and 5-HT(2A) receptors were determined. Compounds 18k and 18m were identified as partial agonists at the D(1) receptor with K(i) values of 50 and 6.3nM, while both compounds act as D(2) receptor antagonists (K(i)=305 and 145nM, respectively) and 5-HT(1A) receptor full agonists (K(i)=149 and 908nM, respectively). These two THPBs compounds exerted antipsychotic actions in animal models. Further electrophysiological studies employing single-unit recording in intact animals demonstrated that 18k-excited dopaminergic (DA) neurons are associated with its 5-HT(1A) receptor agonistic activity. These results suggest that these two compounds targeted to multiple neurotransmitter receptors may present novel lead drugs with new pharmacological profiles for the treatment of schizophrenia.
What problem does this paper attempt to address?